The Discounted Cash Flow (DCF) valuation of Tonix Pharmaceuticals Holding Corp (TNXP) is (3,798.02) USD. With the latest stock price at 28.00 USD, the upside of Tonix Pharmaceuticals Holding Corp based on DCF is -13664.4%.
Based on the latest price of 28.00 USD and our DCF valuation, Tonix Pharmaceuticals Holding Corp (TNXP) is a sell. selling TNXP stocks now will result in a potential gain of 13664.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.2% - 7.7% | 7.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (9,262.78) - (2,417.81) | (3,798.02) |
| Upside | -33181.3% - -8735.0% | -13664.4% |